Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control.

http://www.ncbi.nlm.nih.gov/pubmed/12611903

BRCA1 is a tumor suppressor involved in DNA repair and damage-induced checkpoint controls. In response to DNA damage, BRCA1 relocalizes to nuclear foci at the sites of DNA lesions. However, little is known about the regulation of BRCA1 relocalization following DNA damage. Here we show that mediator of DNA damage checkpoint protein 1 (MDC1), previously named NFBD1 or Kiaa0170, is a proximate mediator of DNA damage responses that regulates BRCA1 function. MDC1 regulates ataxia-telangiectasia-mutated (ATM)-dependent phosphorylation events at the site of DNA damage. Importantly down-regulation of MDC1 abolishes the relocalization and hyperphosphorylation of BRCA1 following DNA damage, which coincides with defective G(2)/M checkpoint control in response to DNA damage. Taken together these data suggest that MDC1 regulates BRCA1 function in DNA damage checkpoint control.

Pubmed ID: 12611903 RIS Download

Mesh terms: Ataxia Telangiectasia Mutated Proteins | BRCA1 Protein | Cell Cycle | Cell Cycle Proteins | DNA Damage | DNA, Complementary | DNA-Binding Proteins | Dose-Response Relationship, Drug | Dose-Response Relationship, Radiation | Down-Regulation | Glutathione Transferase | HeLa Cells | Humans | K562 Cells | Microscopy, Fluorescence | Nuclear Proteins | Phosphorylation | Plasmids | Precipitin Tests | Protein Binding | Protein Kinases | Protein Structure, Tertiary | Protein-Serine-Threonine Kinases | RNA, Small Interfering | S Phase | Time Factors | Trans-Activators | Transfection | Tumor Suppressor Proteins

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.